±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 470  |  »Ø¸´: 1

Malyhon

гæ (СÓÐÃûÆø)

[ÇóÖú] ¼¸¾äÂÛÎÄÇó´óÉñ·­Òë³ÉÖÐÎÄ£¬Ð»Ð»£¬ °ÝÍУ¬°ÝÍÐ

Fibrinogen Adsorption from Human Plasma on Unmodified
and Various Modified PHBV Films. Investigating
the adsorption of fibrinogen from plasma onto biomaterial
surfaces is crucial for implanted scaffolds applied in tissue
engineering because surface-adsorbed fibrinogen from plasma
plays a predominant role in mediating the adhesion of platelets
and also initiates an acute inflammatory response on implanted
surfaces. Therefore, a desirable implanted biomaterial scaffold
should be able to promote cell adhesion and proliferation on the
one hand and to reduce the nonspecific fibrinogen adsorption on the other hand

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

genhunter

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
Malyhon: ½ð±Ò+8, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2015-03-07 12:33:59
Fibrinogen Adsorption from Human Plasma on Unmodified and Various Modified PHBV Films.
Investigating the adsorption of fibrinogen from plasma onto biomaterial surfaces is crucial for implanted scaffolds applied in tissue engineering because surface-adsorbed fibrinogen from plasma plays a predominant role in mediating the adhesion of platelets and also initiates an acute inflammatory response on implanted
surfaces. Therefore, a desirable implanted biomaterial scaffold should be able to promote cell adhesion and proliferation on the one hand and to reduce the nonspecific fibrinogen adsorption on the other hand
ÈËѪ½¬ÏËάµ°°×Ô­ÔÚδÐÞÊκͼ¸ÖÖÐÞÊεÄPHBV±¡Ä¤µÄ±íÃæÎü¸½
Ñо¿ÈËѪ½¬ÖÐÏËάµ°°×Ô­ÔÚÉúÎï²ÄÁϱíÃæµÄÎü¸½¶ÔÖ²ÈëÖ§³ÅÔÚ×éÖ¯¹¤³ÌÓ¦ÓÃÖÁ¹ØÖØÒª£¬ÒòΪ±íÃæÎü¸½µÄѪԴÐÔÏËάµ°°×Ô­ÔÚ²ÎÓëѪС°åÕ³Á¬ºÍÒý·¢»úÌå¶ÔÖ²ÈëÎï±íÃæ²úÉú¼±ÐÔÑ×Ö¢·´Ó¦·½ÃæÆð×ÅÖØÒªµÄ×÷Óá£Òò´Ë£¬ÀíÏëµÄÖ²ÈëÉúÎï²ÄÁÏÖ§³ÅÓ¦¸ÃÒ»·½Ãæ¾ß±¸´Ù½øÏ¸°ûÕ³Á¬ºÍÔöÉúµÄÄÜÁ¦£¬¶øÍ¬Ê±Òª¼õÉÙÏËάµ°°×Ô­µÄ·ÇÌØÒìÐÔÎü¸½¡£
Àë³É¹¦»¹²îÒ»µã
2Â¥2015-03-06 11:36:54
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ Malyhon µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +4 ºôºô£¿~+123456 2026-04-05 4/200 2026-04-05 01:05 by wxiongid
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á +11 ŬÁ¦·Ü¶·112 2026-04-04 11/550 2026-04-04 20:51 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 302Çóµ÷¼ÁÒ»Ö¾Ô¸»ªÖÐʦ·¶´óѧ +8 С½­Ð¡½­½­½­ 2026-04-02 8/400 2026-04-04 19:50 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 325Çóµ÷¼Á +4 ´º·ç²»½èÒâ 2026-04-04 4/200 2026-04-04 14:46 by ÏæÅ©´¢ÄܲÄÁÏ
[¿¼ÑÐ] 309Çóµ÷¼Á +6 ÁõÁõÁõ1231 2026-04-02 7/350 2026-04-04 13:41 by liucky
[¿¼ÑÐ] ÍÁľ304Çóµ÷¼Á +4 ÍÃͻͻͻ£¬ 2026-03-31 4/200 2026-04-04 13:34 by 1753564080
[¿¼ÑÐ] 265Çóµ÷¼Á +17 ÁÖÉîÎÂÀ½ 2026-04-01 20/1000 2026-04-04 01:09 by userper
[¿¼ÑÐ] 320µ÷¼Á +4 ũҵ¹¤³ÌÓëÐÅÏ¢¼ 2026-04-03 4/200 2026-04-03 21:40 by lbsjt
[¿¼ÑÐ] 070300Ò»Ö¾Ô¸211£¬312·ÖÇóµ÷¼ÁԺУ +16 С»ÆÑ¼±¦ 2026-03-30 16/800 2026-04-03 19:53 by lijunpoly
[¿¼ÑÐ] ¹¤¿Æ341·Öµ÷¼Á +3 Âå¶àÂÞ 2026-04-03 3/150 2026-04-03 14:20 by 1753564080
[¿¼ÑÐ] 11408£¬284·Ö£¬¶þÕ½Õæ³ÏÇóµ÷¼Á +4 12.27 2026-04-02 4/200 2026-04-03 14:14 by dxiaoxin
[¿¼ÑÐ] 320Çóµ÷¼Á +3 ũҵ¹¤³ÌÓëÐÅÏ¢¼ 2026-04-03 3/150 2026-04-03 11:40 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] ר˶ 351 086100 Ò²ÊÇ¿¼µÄ²Ä¿Æ»ù ±¾¿ÆÒ²ÊDzÄÁÏ +8 202451007219 2026-04-02 8/400 2026-04-03 09:50 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 366Çóµ÷¼ÁÒ»Ö¾Ô¸¶«±±´óѧ +8 ÔËÆøÀ´µÃÈôÓÐËÆÎ 2026-04-02 8/400 2026-04-02 21:39 by dongzh2009
[¿¼ÑÐ] 285Çóµ÷¼Á +14 AZMK 2026-04-02 14/700 2026-04-02 15:54 by ÉϾÅÌìÀ¿Ô£¨ºÃÔ
[¿¼ÑÐ] 311Çóµ÷¼Á +14 À¶ÔÂÁÁÁÁ 2026-03-30 14/700 2026-04-02 12:18 by 1753564080
[¿¼ÑÐ] 272Çóµ÷¼Á£¬½ÓÊÜ¿çרҵµ÷¼Á£¡ +4 ÏÐÓ㬠2026-03-31 4/200 2026-04-02 11:18 by guyan1000
[¿¼ÑÐ] 070300»¯Ñ§279Çóµ÷¼Á +15 ¹þ¹þ¹þ^_^ 2026-03-31 17/850 2026-04-01 21:37 by ¸øÄãÄã×¢ÒâÐÝÏ¢
[¿¼ÑÐ] 085600£¬320·ÖÇóµ÷¼Á +5 ´ó²öС×Ó 2026-04-01 6/300 2026-04-01 19:40 by ÌÆãå¶ù
[¿¼ÑÐ] ¹þ¶û±õ¹¤Òµ´óѧ²ÄÁÏÓ뻯¹¤×¨Ë¶378Çóµ÷¼Á +3 Ëþ±ÈÎÚ˹ 2026-03-30 3/150 2026-03-30 22:55 by Î޼ʵIJÝÔ­
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û